1-methyl-1,2,3,4-tetrahydroisoquinoline has been researched along with rotenone in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Antkiewicz-Michaluk, L; Bojarski, AJ; Karolewicz, B; Michaluk, J; Romańska, I; Vetulani, J | 1 |
| Antkiewicz-Michaluk, L; Bojarski, A; Michaluk, J; Romaska, I; Vetulani, J; Wardas, J | 1 |
| Hirobe, M; Kotake, Y; Ohta, S; Okuda, K; Sekiya, Y; Taguchi, R; Tasaki, Y | 1 |
| Antkiewicz-Michaluk, L; Bojarski, A; Michaluk, J; Romańska, I; Wąsik, A | 1 |
4 other study(ies) available for 1-methyl-1,2,3,4-tetrahydroisoquinoline and rotenone
| Article | Year |
|---|---|
1-methyl-1,2,3,4-tetrahydroisoquinoline protects against rotenone-induced mortality and biochemical changes in rat brain.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Body Weight; Brain; Corpus Striatum; Dopamine; Dopamine Antagonists; Dose-Response Relationship, Drug; Homovanillic Acid; Insecticides; Isoquinolines; Male; Nucleus Accumbens; Rats; Rats, Wistar; Rotenone; Substantia Nigra; Survival Rate; Tetrahydroisoquinolines | 2003 |
Protective effect of 1-methyl-1,2,3,4-tetrahydroisoquinoline against dopaminergic neurodegeneration in the extrapyramidal structures produced by intracerebral injection of rotenone.
Topics: Animals; Basal Ganglia Diseases; Brain Chemistry; Dopamine; Injections; Injections, Subcutaneous; Male; Medial Forebrain Bundle; Neostriatum; Nerve Degeneration; Neuroprotective Agents; Presynaptic Terminals; Rats; Rats, Wistar; Rotenone; Serotonin; Stereotaxic Techniques; Substantia Nigra; Tetrahydroisoquinolines; Uncoupling Agents | 2004 |
Neuroprotective effect of 1-methyl-1,2,3,4-tetrahydroisoquinoline on cultured rat mesencephalic neurons in the presence or absence of various neurotoxins.
Topics: Animals; Cell Survival; Cells, Cultured; Dose-Response Relationship, Drug; Female; Male; Mesencephalon; Mice; Mice, Inbred C57BL; Neurons; Neuroprotective Agents; Oxidopamine; Pregnancy; Rats; Rats, Wistar; Rotenone; Tetrahydroisoquinolines | 2005 |
Both stereoselective (R)- and (S)-1-Methyl-1,2,3,4-tetrahydroisoquinoline enantiomers protect striatal terminals against rotenone-induced suppression of dopamine release.
Topics: Analysis of Variance; Animals; Corpus Striatum; Dopamine; Dopamine Antagonists; Drug Administration Schedule; Homovanillic Acid; Injections, Subcutaneous; Insecticides; Male; Microdialysis; Motor Activity; Rats; Rats, Wistar; Rotenone; Stereoisomerism; Tetrahydroisoquinolines; Time Factors | 2011 |